BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004;99:1160-1174. [PMID: 15180741 DOI: 10.1111/j.1572-0241.2004.30110.x] [Cited by in Crossref: 400] [Cited by in F6Publishing: 353] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS. Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease. J Korean Med Sci. 2010;25:67-74. [PMID: 20052350 DOI: 10.3346/jkms.2010.25.1.67] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
2 Elesawy BH, Abd El Hafez A, Dorgham LS, El-Askary A. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring. Pathol Res Pract. 2014;210:922-928. [PMID: 25123964 DOI: 10.1016/j.prp.2014.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Peng B, Huang X, Nakayasu ES, Petersen JR, Qiu S, Almeida IC, Zhang JY. Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis. J Proteome Res 2013;12:1789-96. [PMID: 23458688 DOI: 10.1021/pr3011342] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
4 Ozimok CJ, Kielar AZ, Shabana WM. Efficacy and Accessibility of a Novel Liver Fibrosis Evaluation Program. Academic Radiology 2015;22:814-9. [DOI: 10.1016/j.acra.2015.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Guo Y, Liang X, Meng M, Chen H, Wei X, Li M, Li J, Huang R, Wei J. Hepatoprotective effects of Yulangsan flavone against carbon tetrachloride (CCl4)-induced hepatic fibrosis in rats. Phytomedicine 2017;33:28-35. [PMID: 28887917 DOI: 10.1016/j.phymed.2017.07.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
6 Yokoyama H, Masaki T, Inoue I, Nakamura M, Mezaki Y, Saeki C, Oikawa T, Saruta M, Takahashi H, Ikegami M, Hano H, Ikejima K, Kojima S, Matsuura T. Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease. Heliyon 2019;5:e01231. [PMID: 30815603 DOI: 10.1016/j.heliyon.2019.e01231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
7 Li H, Chen TW, Chen XL, Zhang XM, Li ZL, Zeng NL, Zhou L, Wang LY, Tang HJ, Li CP, Li L, Xie XY. Magnetic resonance-based total liver volume and magnetic resonance-diffusion weighted imaging for staging liver fibrosis in mini-pigs. World J Gastroenterol 2012;18:7225-33. [PMID: 23326127 DOI: 10.3748/wjg.v18.i48.7225] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Batheja M, Vargas H, Silva AM, Walker F, Chang YH, De Petris G, Silva AC. Magnetic resonance elastography (MRE) in assessing hepatic fibrosis: performance in a cohort of patients with histological data. Abdom Imaging. 2015;40:760-765. [PMID: 25542217 DOI: 10.1007/s00261-014-0321-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
9 Haukeland JW, Lorgen I, Schreiner LT, Frigstad S, Brandsæter B, Bjøro K, Bang C, Raknerud N, Konopski Z. Incidence rates and causes of cirrhosis in a Norwegian population. Scandinavian Journal of Gastroenterology 2009;42:1501-8. [DOI: 10.1080/00365520701478014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
10 Spano D, Cimmino F, Capasso M, D’angelo F, Zambrano N, Terracciano L, Iolascon A. Changes of the Hepatic Proteome in Hepatitis B-Infected Mouse Model at Early Stages of Fibrosis. J Proteome Res 2008;7:2642-53. [DOI: 10.1021/pr7006522] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
11 Ekiz F, Yüksel O, Koçak E, Yılmaz B, Altınbaş A, Çoban S, Yüksel I, Üsküdar O, Köklü S. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011;25:162-5. [PMID: 21567462 DOI: 10.1002/jcla.20450] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
12 Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42 Suppl:S22-S36. [PMID: 15777570 DOI: 10.1016/j.jhep.2004.12.008] [Cited by in Crossref: 163] [Cited by in F6Publishing: 142] [Article Influence: 9.6] [Reference Citation Analysis]
13 Erman A, Sathya A, Nam A, Bielecki JM, Feld JJ, Thein HH, Wong WWL, Grootendorst P, Krahn MD. Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: A systematic review and meta-analysis. J Viral Hepat 2018;25:502-13. [PMID: 29239068 DOI: 10.1111/jvh.12846] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
14 Ahmad W, Ijaz B, Hassan S. Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray. J Transl Med 2012;10:41. [PMID: 22397681 DOI: 10.1186/1479-5876-10-41] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
15 Grier S, Lim AK, Patel N, Cobbold JF, Thomas HC, Cox IJ, Taylor-Robinson SD. Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease. World J Gastroenterol. 2006;12:3461-3465. [PMID: 16773702 DOI: 10.3748/wjg.v12.i22.3461] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
16 Pissaia A Jr, Borderie D, Bernard D, Scatton O, Calmus Y, Conti F. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology. Transplant Proc. 2009;41:679-681. [PMID: 19328955 DOI: 10.1016/j.transproceed.2008.12.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
17 Sgouros SN, Vasiliadis KV, Pereira SP. Systematic review: endoscopic and imaging-based techniques in the assessment of portal haemodynamics and the risk of variceal bleeding. Alimentary Pharmacology & Therapeutics 2009;30:965-76. [DOI: 10.1111/j.1365-2036.2009.04135.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
18 Pungpapong S, Nunes DP, Krishna M, Nakhleh R, Chambers K, Ghabril M, Dickson RC, Hughes CB, Steers J, Nguyen JH, Keaveny AP. Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl 2008;14:1294-302. [DOI: 10.1002/lt.21508] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
19 Ito K, Kuno A, Ikehara Y, Sugiyama M, Saito H, Aoki Y, Matsui T, Imamura M, Korenaga M, Murata K. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients. Hepatology. 2012;56:1448-1456. [PMID: 22535703 DOI: 10.1002/hep.25815] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
20 Diktas H, Karacaer Z, Özturk II, Cicek H. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection. Postgrad Med J 2016;92:693-6. [PMID: 27170311 DOI: 10.1136/postgradmedj-2016-134069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Wang YX, Yuan J, Chu ES, Go MY, Huang H, Ahuja AT, Sung JJ, Yu J. T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model. Radiology 2011;259:712-9. [PMID: 21436087 DOI: 10.1148/radiol.11101638] [Cited by in Crossref: 83] [Cited by in F6Publishing: 89] [Article Influence: 8.3] [Reference Citation Analysis]
22 Ma JJ, Ding H, Mao F, Sun HC, Xu C, Wang WP. Assessment of liver fibrosis with elastography point quantification technique in chronic hepatitis B virus patients: a comparison with liver pathological results. J Gastroenterol Hepatol. 2014;29:814-819. [PMID: 24325607 DOI: 10.1111/jgh.12479] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.9] [Reference Citation Analysis]
23 Zhao F, Deng M, Yuan J, Teng GJ, Ahuja AT, Wang YX. Experimental evaluation of accelerated T1rho relaxation quantification in human liver using limited spin-lock times. Korean J Radiol 2012;13:736-42. [PMID: 23118572 DOI: 10.3348/kjr.2012.13.6.736] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
24 Zhang L, Li QY, Duan YY, Yan GZ, Yang YL, Yang RJ. Artificial neural network aided non-invasive grading evaluation of hepatic fibrosis by duplex ultrasonography. BMC Med Inform Decis Mak 2012;12:55. [PMID: 22716936 DOI: 10.1186/1472-6947-12-55] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
25 Peng SS, Jeng YM, Hsu WM, Yang JC, Ho MC. Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients. Eur Radiol 2015;25:2992-3002. [PMID: 25921590 DOI: 10.1007/s00330-015-3716-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
26 Zhang D, Guo Z, Zhang P, Li Y, Su X, You L, Gao M, Liu C, Wu H, Zhang X. Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with (99m)Tc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice. Sci Rep. 2016;6:25377. [PMID: 27150943 DOI: 10.1038/srep25377] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
27 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/JCI200524282.] [Reference Citation Analysis]
28 Stankovic Z. Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol. 2016;22:89-102. [PMID: 26755862 DOI: 10.3748/wjg.v22.i1.89] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
29 Sumer S, Aktug Demir N, Kölgelier S, Cagkan Inkaya A, Arpaci A, Saltuk Demir L, Ural O. The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis. Hepat Mon. 2013;13:e10106. [PMID: 24032040 DOI: 10.5812/hepatmon.10106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
30 Faria SC, Ganesan K, Mwangi I, Shiehmorteza M, Viamonte B, Mazhar S, Peterson M, Kono Y, Santillan C, Casola G. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009;29:1615-1635. [PMID: 19959511 DOI: 10.1148/rg.296095512.] [Reference Citation Analysis]
31 Pickhardt PJ, Malecki K, Kloke J, Lubner MG. Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. American Journal of Roentgenology 2016;207:1194-9. [DOI: 10.2214/ajr.16.16514] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
32 Petitclerc L, Sebastiani G, Gilbert G, Cloutier G, Tang A. Liver fibrosis: Review of current imaging and MRI quantification techniques. J Magn Reson Imaging. 2017;45:1276-1295. [PMID: 27981751 DOI: 10.1002/jmri.25550] [Cited by in Crossref: 89] [Cited by in F6Publishing: 69] [Article Influence: 17.8] [Reference Citation Analysis]
33 Xie Q, Zhou X, Huang P, Wei J, Wang W, Zheng S. The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis. PLoS One. 2014;9:e92772. [PMID: 24736610 DOI: 10.1371/journal.pone.0092772] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
34 Ahmad W, Ijaz B, Gull S, Asad S, Khaliq S, Jahan S, Sarwar MT, Kausar H, Sumrin A, Shahid I. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virol J. 2011;8:53. [PMID: 21299910 DOI: 10.1186/1743-422x-8-53] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
35 Levine RA, Sanderson SO, Ploutz–snyder R, Murray F, Kay E, Hegarty J, Nolan N, Kelleher D, Mcdonald G, O’keane JC, Crowe J. Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D. Clinical Gastroenterology and Hepatology 2006;4:1271-7. [DOI: 10.1016/j.cgh.2006.05.028] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
36 Peveler WJ, Landis RF, Yazdani M, Day JW, Modi R, Carmalt CJ, Rosenberg WM, Rotello VM. A Rapid and Robust Diagnostic for Liver Fibrosis Using a Multichannel Polymer Sensor Array. Adv Mater 2018;30:e1800634. [PMID: 29797373 DOI: 10.1002/adma.201800634] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 9.7] [Reference Citation Analysis]
37 Gudowska M, Gruszewska E, Panasiuk A, Cylwik B, Flisiak R, Świderska M, Szmitkowski M, Chrostek L. Hyaluronic acid concentration in liver diseases. Clin Exp Med 2016;16:523-8. [PMID: 26354758 DOI: 10.1007/s10238-015-0388-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
38 Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, Gallois Y, Ternisien C, Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005;42:1373-1381. [PMID: 16317693 DOI: 10.1002/hep.20935] [Cited by in Crossref: 372] [Cited by in F6Publishing: 310] [Article Influence: 23.3] [Reference Citation Analysis]
39 Sönmez S, Boşat M, Yurtseven N, Yurtseven E. The role of elastography in the assessment of chronic liver disease in children. Afr Health Sci 2019;19:2806-11. [PMID: 32127854 DOI: 10.4314/ahs.v19i3.57] [Reference Citation Analysis]
40 Shteyer E, Ramm GA, Xu C, White FV, Shepherd RW. Outcome after portoenterostomy in biliary atresia: pivotal role of degree of liver fibrosis and intensity of stellate cell activation. J Pediatr Gastroenterol Nutr. 2006;42:93-99. [PMID: 16385261 DOI: 10.1097/01.mpg.0000189324.80323.a6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
41 Cai Y, Liu D, Cui J, Sha Y, Zhou H, Tang N, Wang N, Huang A, Xia J. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e15096. [PMID: 30946368 DOI: 10.1097/MD.0000000000015096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
42 El-Sayed NM, Fathy GM, Abdel-Rahman SA, El-Shafei MA. Cytokine patterns in experimental schistosomiasis mansoni infected mice treated with silymarin. J Parasit Dis 2016;40:922-9. [PMID: 27605811 DOI: 10.1007/s12639-014-0606-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
43 Oshaghi EA, Khodadadi I, Tavilani H, Goodarzi MT. Effect of dill tablet (Anethum graveolens L) on antioxidant status and biochemical factors on carbon tetrachloride-induced liver damage on rat. Int J Appl Basic Med Res 2016;6:111-4. [PMID: 27127740 DOI: 10.4103/2229-516X.179019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 3.6] [Reference Citation Analysis]
44 Shiha G, Seif S, Eldesoky A, Elbasiony M, Soliman R, Metwally A, Zalata K, Mikhail N. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C. Hepatol Int 2017;11:286-91. [PMID: 28425016 DOI: 10.1007/s12072-017-9796-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
45 Sandrasegaran K, Ramaswamy R, Ghosh S, Tahir B, Akisik FM, Saxena R, Kwo P. Diffusion-weighted MRI of the transplanted liver. Clin Radiol. 2011;66:820-825. [PMID: 21621199 DOI: 10.1016/j.crad.2010.12.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Zhu B, Wei L, Rotile N, Day H, Rietz T, Farrar CT, Lauwers GY, Tanabe KK, Rosen B, Fuchs BC, Caravan P. Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model. Hepatology 2017;65:1015-25. [PMID: 28039886 DOI: 10.1002/hep.28930] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
47 Zhang GB, Song YN, Chen QL, Dong S, Lu YY, Su MY, Liu P, Su SB. Actions of Huangqi decoction against rat liver fibrosis: a gene expression profiling analysis. Chin Med. 2015;10:39. [PMID: 26691002 DOI: 10.1186/s13020-015-0066-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
48 Park G, Jones DB, Katelaris P. Value of AST/ALT Ratio as Fibrotic Predictor in Chronic Hepatitis C. Am J Gastroenterology 2005;100:1623-4. [DOI: 10.1111/j.1572-0241.2005.50006_6.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
49 Viana MSVB, Takei K, Collarile Yamaguti DC, Guz B, Strauss E. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Annals of Hepatology 2009;8:26-31. [DOI: 10.1016/s1665-2681(19)31807-1] [Cited by in Crossref: 35] [Article Influence: 2.9] [Reference Citation Analysis]
50 Kelleher TB, Afdhal N. Assessment of liver fibrosis in co-infected patients. J Hepatol 2006;44:S126-31. [PMID: 16352364 DOI: 10.1016/j.jhep.2005.11.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
51 Goyal N, Jain N, Rachapalli V, Cochlin DL, Robinson M. Non-invasive evaluation of liver cirrhosis using ultrasound. Clin Radiol. 2009;64:1056-1066. [PMID: 19822238 DOI: 10.1016/j.crad.2009.05.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
52 Wu S, Ni Y, Liu L, Li H, Lu L, Wang J. Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B. Hepatol Int 2012;6:360-8. [DOI: 10.1007/s12072-011-9328-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
53 Chen S, Sanchez W, Callstrom MR, Gorman B, Lewis JT, Sanderson SO, Greenleaf JF, Xie H, Shi Y, Pashley M. Assessment of liver viscoelasticity by using shear waves induced by ultrasound radiation force. Radiology. 2013;266:964-970. [PMID: 23220900 DOI: 10.1148/radiol.12120837] [Cited by in Crossref: 147] [Cited by in F6Publishing: 92] [Article Influence: 16.3] [Reference Citation Analysis]
54 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/jci200524282] [Cited by in Crossref: 211] [Article Influence: 13.2] [Reference Citation Analysis]
55 Sebastiani G, Gkouvatsos K, Plebani M. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. Clin Chem Lab Med. 2011;49:13-32. [PMID: 20961196 DOI: 10.1515/cclm.2011.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
56 An HS, Choi YH, Song MK, Lee SY, Kim GB, Bae EJ. Early development of hepatic fibrosis after Fontan procedure: A non-invasive study of a subclinical liver disease. Int J Cardiol 2020;320:64-9. [PMID: 32800914 DOI: 10.1016/j.ijcard.2020.08.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 El-attar MM, Rashed HG, Sewify EM, Hassan HE. A suggested algorithm for using serum biomarkers for the diagnosis of liver fibrosis in chronic hepatitis C infection. Arab Journal of Gastroenterology 2010;11:206-11. [DOI: 10.1016/j.ajg.2010.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Orasan OH, Ciulei G, Cozma A, Sava M, Dumitrascu DL. Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies. Clujul Med 2016;89:24-31. [PMID: 27004022 DOI: 10.15386/cjmed-554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
59 Liang B, Li Y, Zhao A, Xie F, Guo Z. Clinical utility of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 concentrations in the assessment of liver fibrosis due to chronic hepatitis B. J Int Med Res. 2012;40:631-639. [PMID: 22613424 DOI: 10.1177/147323001204000225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
60 Sebastiani G, Alberti A. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? J Viral Hepat. 2012;19 Suppl 1:18-32. [PMID: 22233410 DOI: 10.1111/j.1365-2893.2011.01518.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
61 Muhanna N, Doron S, Abu-tair L, Zayyad H, Mahamid M, Amer J, Safadi R. Early fibrosis inhibits hepatocellular carcinoma mediated by free radical effects. Mitochondrion 2013;13:391-8. [DOI: 10.1016/j.mito.2013.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging. 2007;25:122-128. [PMID: 17154179 DOI: 10.1002/jmri.20771] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 8.2] [Reference Citation Analysis]
63 Isman FK, Kucur M, Baysal B, Ozkan F. Evaluation of serum hyaluronic acid level and hyaluronidase activity in acute and chronic hepatitis C. J Int Med Res 2007;35:346-52. [PMID: 17593863 DOI: 10.1177/147323000703500309] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
64 Cheung JS, Fan SJ, Gao DS, Chow AM, Man K, Wu EX. Diffusion tensor imaging of liver fibrosis in an experimental model. J Magn Reson Imaging. 2010;32:1141-1148. [PMID: 21031520 DOI: 10.1002/jmri.22367] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
65 Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging. 2013;37:544-555. [PMID: 23423795 DOI: 10.1002/jmri.23731] [Cited by in Crossref: 354] [Cited by in F6Publishing: 283] [Article Influence: 44.3] [Reference Citation Analysis]
66 Chaudhuri D, Ghate NB, Panja S, Das A, Mandal N. Wild Edible Fruit of Prunus nepalensis Ser. (Steud), a Potential Source of Antioxidants, Ameliorates Iron Overload-Induced Hepatotoxicity and Liver Fibrosis in Mice. PLoS One 2015;10:e0144280. [PMID: 26633891 DOI: 10.1371/journal.pone.0144280] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
67 Ekiz F, Yuksel İ, Arikök AT, Yilmaz B, Altinbas A, Aktas B, Deveci M, Basar O, Coban S, Yuksel O. Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B? Hepatol Int 2016;10:602-5. [PMID: 26416085 DOI: 10.1007/s12072-015-9666-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Wagner G, Ryan G, Osilla KC, Bhatti L, Goetz M, Witt M. Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection. AIDS Patient Care STDS 2009;23:715-25. [PMID: 19663714 DOI: 10.1089/apc.2009.0049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
69 Huang C, Seah JJ, Tan CK, Kam JW, Tan J, Teo EK, Kwek A, Wong YJ, Tan M, Ang TL, Kumar R. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease. Clin Res Hepatol Gastroenterol 2021;45:101528. [PMID: 33268036 DOI: 10.1016/j.clinre.2020.08.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 He Y, Yan Y, Zhang S. Quantitative liver surface nodularity score based on imaging for assessment of early cirrhosis in patients with chronic liver disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e23636. [PMID: 33530167 DOI: 10.1097/MD.0000000000023636] [Reference Citation Analysis]
71 Åberg F, Danford CJ, Thiele M, Talbäck M, Rasmussen DN, Jiang ZG, Hammar N, Nasr P, Ekstedt M, But A, Puukka P, Krag A, Sundvall J, Erlund I, Salomaa V, Stål P, Kechagias S, Hultcrantz R, Lai M, Afdhal N, Jula A, Männistö S, Lundqvist A, Perola M, Färkkilä M, Hagström H. A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease. Hepatol Commun 2021;5:1021-35. [PMID: 34141987 DOI: 10.1002/hep4.1700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
72 Borman MA, Ladak F, Crotty P, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Duarte-Rojo A, Elkashab M, Myers RP. The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients. Hepatol Int 2013;7:592-9. [PMID: 26201792 DOI: 10.1007/s12072-012-9401-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
73 Li Q, Yu B, Tian X, Cui X, Zhang R, Guo Q. Deep residual nets model for staging liver fibrosis on plain CT images. Int J Comput Assist Radiol Surg 2020;15:1399-406. [PMID: 32556922 DOI: 10.1007/s11548-020-02206-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
74 Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006;12:3682-94. [PMID: 16773685 DOI: 10.3748/wjg.v12.i23.3682] [Cited by in CrossRef: 170] [Cited by in F6Publishing: 159] [Article Influence: 11.3] [Reference Citation Analysis]
75 Zhou J, Song L, Zhao H, Yan L, Ma A, Xie S, Zhang X, Zhang D, Xie Q, Zhang G, Shang J, Cheng J, Zhao W, Zou Z, Zhang M, Xia N, Wang G. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase. Sci Rep 2017;7:2747. [PMID: 28584279 DOI: 10.1038/s41598-017-03102-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
76 Hung TM, Chang SC, Yu WH, Wang YW, Huang C, Lu SC, Lee PH, Chang MF. A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis. Hepatology 2009;50:1184-93. [PMID: 19676133 DOI: 10.1002/hep.23137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
77 Lieber CS, Weiss DG, Paronetto F. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol Clin Exp Res. 2008;32:1031-1039. [PMID: 18422837 DOI: 10.1111/j.1530-0277.2008.00664.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
78 Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Guido M, Bourliere M, Noventa F, Alberti A. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology. 2009;49:1821-1827. [PMID: 19291784 DOI: 10.1002/hep.22859] [Cited by in Crossref: 126] [Cited by in F6Publishing: 106] [Article Influence: 10.5] [Reference Citation Analysis]
79 Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Leutner M, Pirisi M. Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C. Clin Chem Lab Med 2008;46:253-9. [PMID: 18324909 DOI: 10.1515/CCLM.2008.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
80 Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol. 2009;193:14-27. [PMID: 19542391 DOI: 10.2214/ajr.09.2601] [Cited by in Crossref: 128] [Cited by in F6Publishing: 44] [Article Influence: 10.7] [Reference Citation Analysis]
81 Lee MJ, Kim MJ, Yoon CS, Han SJ, Park YN. Evaluation of liver fibrosis with T2 relaxation time in infants with cholestasis: comparison with normal controls. Pediatr Radiol 2011;41:350-4. [PMID: 20959973 DOI: 10.1007/s00247-010-1874-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
82 Ackerman T, Geerts A, Van Vlierberghe H, De Backer J, François K. Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening. Pediatr Cardiol 2018;39:1604-13. [PMID: 30032312 DOI: 10.1007/s00246-018-1937-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
83 Micheloud D, Salcedo M, Bañares R, Rincón D, Lorente R, Muñoz-Fernández MA, Resino S. Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence. Transpl Infect Dis 2009;11:183-8. [PMID: 19254326 DOI: 10.1111/j.1399-3062.2009.00370.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
84 Kim TY, Kim JY, Sohn JH, Lee HS, Bang SY, Kim Y, Kim MY, Jeong WK. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis. J Ultrasound Med 2015;34:1621-30. [PMID: 26269292 DOI: 10.7863/ultra.15.14.10035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
85 Salas AL, Montezuma TD, Fariña GG, Reyes-Esparza J, Rodríguez-Fragoso L. Genistein modifies liver fibrosis and improves liver function by inducing uPA expression and proteolytic activity in CCl4-treated rats. Pharmacology 2008;81:41-9. [PMID: 17823541 DOI: 10.1159/000107968] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
86 Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009;15:2190-203. [PMID: 19437558 DOI: 10.3748/wjg.15.2190] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
87 Ito K, Murotani K, Nakade Y, Inoue T, Nakao H, Sumida Y, Kamada Y, Yoneda M. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: A meta-analysis: WFA+-M2BP and liver fibrosis. Journal of Gastroenterology and Hepatology 2017;32:1922-30. [DOI: 10.1111/jgh.13802] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
88 Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968-73. [PMID: 17255218 DOI: 10.1136/gut.2006.111302] [Cited by in Crossref: 572] [Cited by in F6Publishing: 505] [Article Influence: 40.9] [Reference Citation Analysis]
89 Sookoian S, Fernández MA, Castaño G. Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study. World J Gastroenterol 2005;11:7560-3. [PMID: 16437678 DOI: 10.3748/wjg.v11.i48.7560] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
90 Valva P, Ríos DA, De Matteo E, Preciado MV. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol 2016;22:1367-81. [PMID: 26819506 DOI: 10.3748/wjg.v22.i4.1367] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
91 Ergelen R, Yilmaz Y, Asedov R, Celikel C, Akin H, Bugdayci O, Altun E, Tuney D. Comparison of Doppler ultrasound and transient elastography in the diagnosis of significant fibrosis in patients with nonalcoholic steatohepatitis. Abdom Radiol (NY) 2016;41:1505-10. [PMID: 26960729 DOI: 10.1007/s00261-016-0699-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
92 Lebensztejn DM, Sobaniec-Lotowska ME, Kaczmarski M, Voelker M, Schuppan D. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol. 2006;12:3338-3343. [PMID: 16733849 DOI: 10.3748/wjg.v12.i21.3338] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
93 Jepsen P, Vilstrup H, Sørensen HT. Alcoholic cirrhosis in Denmark - population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol. 2008;8:3. [PMID: 18261240 DOI: 10.1186/1471-230x-8-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
94 Pellot-barakat C, Lefort M, Chami L, Labit M, Frouin F, Lucidarme O. Automatic Assessment of Shear Wave Elastography Quality and Measurement Reliability in the Liver. Ultrasound in Medicine & Biology 2015;41:936-43. [DOI: 10.1016/j.ultrasmedbio.2014.11.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
95 Yu H, Buch K, Li B, O'brien M, Soto J, Jara H, Anderson SW. Utility of texture analysis for quantifying hepatic fibrosis on proton density MRI: Hepatic Fibrosis on Proton Density MRI. J Magn Reson Imaging 2015;42:1259-65. [DOI: 10.1002/jmri.24898] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
96 Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta. 2007;381:107-113. [PMID: 17399697 DOI: 10.1016/j.cca.2007.02.038] [Cited by in Crossref: 132] [Cited by in F6Publishing: 107] [Article Influence: 9.4] [Reference Citation Analysis]
97 Yamamura K, Sakamoto I, Morihana E, Hirata Y, Nagata H, Yamasaki Y, Okumura Y, Kohashi K, Koto K, Tsutsui H, Ohga S. Elevated non-invasive liver fibrosis markers and risk of liver carcinoma in adult patients after repair of tetralogy of Fallot. International Journal of Cardiology 2019;287:121-6. [DOI: 10.1016/j.ijcard.2019.04.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
98 Aykut UE, Akyuz U, Yesil A, Eren F, Gerin F, Ergelen R, Celikel CA, Yilmaz Y. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scand J Gastroenterol 2014;49:1343-8. [PMID: 25259621 DOI: 10.3109/00365521.2014.958099] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
99 Benlloch S, Berenguer M, Prieto M, Rayón JM, Aguilera V, Berenguer J. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index. Liver Transpl. 2005;11:456-462. [PMID: 15776403 DOI: 10.1002/lt.20381] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
100 Chandarana H, Do RK, Mussi TC, Jensen JH, Hajdu CH, Babb JS, Taouli B. The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis. AJR Am J Roentgenol. 2012;199:803-808. [PMID: 22997371 DOI: 10.2214/ajr.11.7541] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
101 Makhlouf MM, Osman MA, Saleh SAB, Yousry WA, Soliman ML, Doss WH, Wahba FS. Serum angiopoietin-2 as a noninvasive diagnostic marker of stages of liver fibrosis in chronic hepatitis C patients. Egypt J Intern Med 2016;28:140-8. [DOI: 10.4103/1110-7782.203293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Park DW, Lee YJ, Chang W, Park JH, Lee KH, Kim YH, Kang NK, Chung JW, Jang HY, Ahn S, Kim H, Jeong SH, Kim JW, Jang ES. Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease. PLoS One 2019;14:e0212771. [PMID: 30856201 DOI: 10.1371/journal.pone.0212771] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
103 Cheung KJ, Tilleman K, Deforce D, Colle I, Moreno C, Gustot T, Van Vlierberghe H. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2011;23:701-710. [PMID: 21623191 DOI: 10.1097/meg.0b013e3283471b74] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
104 Furukawa T, Akimoto K, Ohtsuki M, Sato K, Suzuki M, Takahashi K, Kishiro M, Shimizu T, Kawasaki S. Non-invasive assessment of liver fibrosis in patients after the Fontan operation: Liver fibrosis after Fontan operation. Pediatrics International 2011;53:980-4. [DOI: 10.1111/j.1442-200x.2011.03497.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
105 Kwon JH, Park ST, Kim GD, You CR, Kim JD, Woo HY, Jang JW, Kim CW, Bae SH, Choi JY, Yoon SK. The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease. Korean J Hepatol 2009;15:59. [DOI: 10.3350/kjhep.2009.15.1.59] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
106 Tarçin O, Gedik N, Karakoyun B, Tahan V, Sood G, Celikel C, Tözün N. Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats. Dig Dis Sci. 2008;53:1938-1945. [PMID: 17999185 DOI: 10.1007/s10620-007-0073-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
107 Varenika V, Fu Y, Maher JJ, Gao D, Kakar S, Cabarrus MC, Yeh BM. Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT. Radiology 2013;266:151-8. [PMID: 23169796 DOI: 10.1148/radiol.12112452] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
108 Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging. 2015;40:818-834. [PMID: 24711064 DOI: 10.1007/s00261-014-0137-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 8.3] [Reference Citation Analysis]
109 Tae HJ, Jun DW, Choi YY, Kwak MJ, Lee MH. Assessment of risk of complications in cirrhosis using portal thallium scans. World J Gastroenterol 2014;20:228-34. [PMID: 24415876 DOI: 10.3748/wjg.v20.i1.228] [Reference Citation Analysis]
110 Uzunoglu D, Altunbek M, Kuku G, Culha M. Single-Cell Omics in Noninvasive Diagnosis and Testing—Surface-Enhanced Raman Spectroscopy-Based Approach. Single-Cell Omics. Elsevier; 2019. pp. 153-77. [DOI: 10.1016/b978-0-12-814919-5.00008-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Sheen V, Nguyen H, Jimenez M, Agopian V, Vangala S, Elashoff D, Saab S. Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience. J Clin Transl Hepatol 2016;4:20-5. [PMID: 27047768 DOI: 10.14218/JCTH.2015.00034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
112 Schneider AR, Teuber G, Paul K, Nikodem A, Duesterhoeft M, Caspary WF, Stein J. PATIENT AGE IS A STRONG INDEPENDENT PREDICTOR OF 13C-AMINOPYRINE BREATH TEST RESULTS: A COMPARATIVE STUDY WITH HISTOLOGY, DUPLEX-DOPPLER AND A LABORATORY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION. Clin Exp Pharmacol Physiol 2006;33:300-4. [DOI: 10.1111/j.1440-1681.2006.04365.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
113 Chen BB, Hsu CY, Yu CW, Wei SY, Kao JH, Lee HS, Shih TT. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Eur Radiol. 2012;22:171-180. [PMID: 21879400 DOI: 10.1007/s00330-011-2249-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
114 Wu SD, Wang JY, Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study. World J Gastroenterol. 2010;16:501-507. [PMID: 20101779 DOI: 10.3748/wjg.v16.i4.501] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
115 Haimerl M, Utpatel K, Verloh N, Zeman F, Fellner C, Nickel D, Teufel A, Fichtner-Feigl S, Evert M, Stroszczynski C, Wiggermann P. Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis. Sci Rep 2017;7:41429. [PMID: 28128291 DOI: 10.1038/srep41429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
116 Park SH, Choe JY, Kim SK. Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate. Joint Bone Spine. 2010;77:588-592. [PMID: 20471892 DOI: 10.1016/j.jbspin.2010.02.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
117 Ruan D, Shi Y, Jin L, Yang Q, Yu W, Ren H, Zheng W, Chen Y, Zheng N, Zheng M. An ultrasound image-based deep multi-scale texture network for liver fibrosis grading in patients with chronic HBV infection. Liver Int 2021. [PMID: 34219353 DOI: 10.1111/liv.14999] [Reference Citation Analysis]
118 Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835-847. [PMID: 18334275 DOI: 10.1016/j.jhep.2008.02.008] [Cited by in Crossref: 873] [Cited by in F6Publishing: 762] [Article Influence: 67.2] [Reference Citation Analysis]
119 Alghamdi AS, Sanai FM, Ismail M, Alghamdi H, Alswat K, Alqutub A, Altraif I, Shah H, Alfaleh FZ; Saudi Association for the Study of Liver Diseases and Transplantation. SASLT practice guidelines: management of hepatitis C virus infection. Saudi J Gastroenterol 2012;18 Suppl:S1-32. [PMID: 23006491 DOI: 10.4103/1319-3767.101155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
120 Cheng K, Mahato RI. Gene modulation for treating liver fibrosis. Crit Rev Ther Drug Carrier Syst. 2007;24:93-146. [PMID: 17725523 DOI: 10.1615/critrevtherdrugcarriersyst.v24.i2.10] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
121 Pickhardt PJ, Malecki K, Hunt OF, Beaumont C, Kloke J, Ziemlewicz TJ, Lubner MG. Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis. Eur Radiol 2017;27:3060-8. [PMID: 27858212 DOI: 10.1007/s00330-016-4648-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
122 Chen B, Schreiber RA, Human DG, Potts JE, Guttman OR. Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography. Can J Gastroenterol Hepatol 2016;2016:7125193. [PMID: 27656638 DOI: 10.1155/2016/7125193] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 4.6] [Reference Citation Analysis]
123 Ahmed Hassan E, Sharaf El-Din Abd El-Rehim A, Ahmed Sayed ZE, Farah Mohamed Kholef E, Sabry A, Abd El-Rehim Abo Elhagag N. VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C. Hepatol Res 2017;47:1408-16. [PMID: 28247581 DOI: 10.1111/hepr.12884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
124 Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Pirisi M. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index. Clin Biochem 2006;39:339-43. [PMID: 16487951 DOI: 10.1016/j.clinbiochem.2006.01.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
125 Ibrahim HR, El-hamid AA, Tohamy A, Habba MR. Diagnostic value of apparent diffusion coefficient calculated with diffusion-weighted MRI for quantification of liver fibrosis. The Egyptian Journal of Radiology and Nuclear Medicine 2011;42:119-31. [DOI: 10.1016/j.ejrnm.2011.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Navrotsky AN. [Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis]. Ter Arkh 2016;88:149-55. [PMID: 28635835 DOI: 10.17116/terarkh20168811149-155] [Reference Citation Analysis]
127 Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, Cho SW, Han KH, Chon CY, Moon YM. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007;27:969-976. [PMID: 17696936 DOI: 10.1111/j.1478-3231.2007.01519.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 5.1] [Reference Citation Analysis]
128 Shen FF, Wang Y, Wang YF, Zheng RD, Xian JC, Shi JP, Qu Y, Dong YW, Xu MY, Lu LG. Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model. J Transl Med 2018;16:166. [PMID: 29914513 DOI: 10.1186/s12967-018-1538-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Guilbert T, Odin C, Le Grand Y, Gailhouste L, Turlin B, Ezan F, Désille Y, Baffet G, Guyader D. A robust collagen scoring method for human liver fibrosis by second harmonic microscopy. Opt Express 2010;18:25794-807. [PMID: 21164924 DOI: 10.1364/OE.18.025794] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
130 Boursier J, Konaté A, Gorea G, Reaud S, Quemener E, Oberti F, Hubert-Fouchard I, Dib N, Calès P. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol. 2008;6:1263-1269. [PMID: 18995217 DOI: 10.1016/j.cgh.2008.07.006] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 6.7] [Reference Citation Analysis]
131 Lim AKP, Patel N, Hamilton G, Mylvahan K, Kuo Y, Goldin RD, Taylor-robinson SD. 31P MR Spectroscopy in Assessment of Response to Antiviral Therapy for Hepatitis C Virus–Related Liver Disease. American Journal of Roentgenology 2007;189:819-23. [DOI: 10.2214/ajr.07.2418] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
132 Toson EA, Shiha GE, Abdelgaleel AE. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients. Ann Hepatol 2017;16:862-73. [PMID: 29055924 DOI: 10.5604/01.3001.0010.5276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Li S, Liu X, Wei L, Wang H, Zhang J, Wei H, Qian X, Jiang Y, He F. Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategy. Sci China Life Sci 2011;54:393-402. [PMID: 21574042 DOI: 10.1007/s11427-011-4165-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
134 Deng M, Zhao F, Yuan J, Ahuja AT, Wang YX. Liver T1ρ MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence. Br J Radiol 2012;85:e590-5. [PMID: 22422392 DOI: 10.1259/bjr/98745548] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
135 Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, Kuipers EJ, de Knegt RJ, van Vuuren AJ. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol. 2011;46:962-972. [PMID: 21623677 DOI: 10.3109/00365521.2011.574725] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
136 Mustapic S, Ziga S, Matic V, Bokun T, Radic B, Lucijanic M, Marusic S, Babic Z, Grgurevic I. Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome. Can J Gastroenterol Hepatol 2018;2018:8490242. [PMID: 30211140 DOI: 10.1155/2018/8490242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
137 Trifan A, Stanciu C. Checkmate to liver biopsy in chronic hepatitis C? World J Gastroenterol. 2012;18:5514-5520. [PMID: 23112543 DOI: 10.3748/wjg.v18.i39.5514] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
138 Nallagangula KS, Nagaraj SK, Venkataswamy L, Chandrappa M. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA 2018;4:FSO250. [PMID: 29255622 DOI: 10.4155/fsoa-2017-0083] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 11.8] [Reference Citation Analysis]
139 Hu XR, Cui XN, Hu QT, Chen J. Value of MR diffusion imaging in hepatic fibrosis and its correlations with serum indices. World J Gastroenterol. 2014;20:7964-7970. [PMID: 24976733 DOI: 10.3748/wjg.v20.i24.7964] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
140 Shimizu M, Miyamoto K, Nishihara Y, Izumi G, Sakai S, Inai K, Nishikawa T, Nakanishi T. Risk factors and serological markers of liver cirrhosis after Fontan procedure. Heart Vessels 2016;31:1514-21. [PMID: 26386570 DOI: 10.1007/s00380-015-0743-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
141 Wu H, Fiel M, Schiano T, Gil J. Image segmentation of liver fibrosis. Journal of Microscopy 2008;231:70-80. [DOI: 10.1111/j.1365-2818.2008.02018.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
142 Shayesteh M, Shayesteh AA, Motamedfar A, Tahmasebi M, Bagheri S, Gharibvand MM. The clinical value of the apparent diffusion coefficient of liver magnetic resonance images in patients with liver fibrosis compared to healthy subjects. J Family Med Prim Care 2018;7:1501-5. [PMID: 30613549 DOI: 10.4103/jfmpc.jfmpc_299_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
143 Lin H, Fan T, Sui J, Wang G, Chen J, Zhuo S, Zhang H. Recent advances in multiphoton microscopy combined with nanomaterials in the field of disease evolution and clinical applications to liver cancer. Nanoscale 2019;11:19619-35. [PMID: 31599299 DOI: 10.1039/c9nr04902a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
144 Voieta I, Queiroz LCD, Andrade LM, Silva LCS, Fontes VF, Barbosa Jr A, Resende V, Petroianu A, Andrade Z, Antunes CM, Lambertucci JR. Imaging techniques and histology in the evaluation of liver fibrosis in hepatosplenic schistosomiasis mansoni in Brazil: a comparative study. Mem Inst Oswaldo Cruz 2010;105:414-21. [DOI: 10.1590/s0074-02762010000400011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
145 Ng LC, Lee YY, Lee CK, Wong SM. A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia. Int J Dermatol. 2013;52:102-105. [PMID: 23278617 DOI: 10.1111/j.1365-4632.2011.05436.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
146 Bakan AA, Inci E, Bakan S, Gokturk S, Cimilli T. Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol. 2012;22:682-687. [PMID: 21984447 DOI: 10.1007/s00330-011-2295-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
147 Gressner AM, Yagmur E, Lahme B, Gressner O, Stanzel S. Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem. 2006;52:1815-1817. [PMID: 16858074 DOI: 10.1373/clinchem.2006.070466] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
148 Bahl G, Cruite I, Wolfson T, Gamst AC, Collins JM, Chavez AD, Barakat F, Hassanein T, Sirlin CB. Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images. J Magn Reson Imaging 2012;36:1154-61. [PMID: 22851409 DOI: 10.1002/jmri.23759] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
149 Goodman ZD, Becker RL, Pockros PJ, Afdhal NH. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology. 2007;45:886-894. [PMID: 17393526 DOI: 10.1002/hep.21595] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 7.9] [Reference Citation Analysis]
150 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1056/s0140-6736(08)60383-9] [Reference Citation Analysis]
151 Cheung KJ, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Proteomics in liver fibrosis is more than meets the eye: . European Journal of Gastroenterology & Hepatology 2008;20:450-64. [DOI: 10.1097/meg.0b013e3282f4de92] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
152 Piao RL, Brigstock DR, Zhu J, Zhang ML, Gao RP. Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis. World J Gastroenterol. 2012;18:2280-2286. [PMID: 22611323 DOI: 10.3748/wjg.v18.i18.2280] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
153 Adebajo CO, Talwalkar JA, Poterucha JJ, Kim WR, Charlton MR. Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis. Liver Transpl. 2012;18:323-331. [PMID: 22140010 DOI: 10.1002/lt.22460] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
154 Guo SL, Su LN, Zhai YN, Chirume WM, Lei JQ, Zhang H, Yang L, Shen XP, Wen XX, Guo YM. The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis. Clin Radiol 2017;72:242-6. [PMID: 28341030 DOI: 10.1016/j.crad.2016.10.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
155 Planz VB, Lubner MG, Pickhardt PJ. Volumetric analysis at abdominal CT: oncologic and non-oncologic applications. Br J Radiol 2019;92:20180631. [PMID: 30457881 DOI: 10.1259/bjr.20180631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
156 Kelleher TB, Afdhal N. Noninvasive Assessment of Liver Fibrosis. Clinics in Liver Disease 2005;9:667-83. [DOI: 10.1016/j.cld.2005.08.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
157 Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med. 2007;11:1031-1051. [PMID: 17979881 DOI: 10.1111/j.1582-4934.2007.00092.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
158 Zhou K, Lu LG. Assessment of fibrosis in chronic liver diseases. Journal of Digestive Diseases 2009;10:7-14. [DOI: 10.1111/j.1751-2980.2008.00356.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
159 Kim BK, Kim DY, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Han KH. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int. 2010;30:546-553. [PMID: 20074094 DOI: 10.1111/j.1478-3231.2009.02192.x] [Cited by in Crossref: 144] [Cited by in F6Publishing: 132] [Article Influence: 13.1] [Reference Citation Analysis]
160 Iacobellis A, Fusilli S, Mangia A, Clemente R, Festa V, Giacobbe A, Facciorusso D, Niro G, Conoscitore P, Andriulli A. Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis. Aliment Pharmacol Ther. 2005;22:769-774. [PMID: 16225484 DOI: 10.1111/j.1365-2036.2005.02633.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
161 Fuchs BC, Wang H, Yang Y, Wei L, Polasek M, Schühle DT, Lauwers GY, Parkar A, Sinskey AJ, Tanabe KK, Caravan P. Molecular MRI of collagen to diagnose and stage liver fibrosis. J Hepatol 2013;59:992-8. [PMID: 23838178 DOI: 10.1016/j.jhep.2013.06.026] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 11.8] [Reference Citation Analysis]
162 Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C. Clin Chim Acta. 2007;381:119-123. [PMID: 17442291 DOI: 10.1016/j.cca.2007.02.046] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
163 Castera L. Assessing liver fibrosis. Expert Rev Gastroenterol Hepatol. 2008;2:541-552. [PMID: 19072402 DOI: 10.1586/17474124.2.4.541] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
164 Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Takayama Y, Yoshizumi T, Hida T, Oda Y, Okuaki T, Honda H. Quantitative evaluation of liver function and pathology with hepatocyte fraction on Gadoxetic acid-enhanced MR imaging. Magn Reson Imaging 2020;73:125-9. [PMID: 32860870 DOI: 10.1016/j.mri.2020.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
165 Marfà S, Crespo G, Reichenbach V, Forns X, Casals G, Morales-Ruiz M, Navasa M, Jiménez W. Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease. PLoS One 2014;9:e109254. [PMID: 25275549 DOI: 10.1371/journal.pone.0109254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
166 Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Schlaphoff V, Dienes HP, Bock TC, Manns MP, Wedemeyer H; HIDT-1 Study Group. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int 2010;30:430-7. [PMID: 19840253 DOI: 10.1111/j.1478-3231.2009.02140.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
167 Lieber CS, Weiss DG, Morgan TR, Paronetto F. Aspartate Aminotransferase to Platelet Ratio Index in Patients with Alcoholic Liver Fibrosis. Am J Gastroenterol 2006;101:1500-8. [DOI: 10.1111/j.1572-0241.2006.00610.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 5.0] [Reference Citation Analysis]
168 Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, de Ledinghen V, Neau D. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am J Gastroenterol. 2008;103:1973-1980. [PMID: 18796094 DOI: 10.1111/j.1572-0241.2008.01954.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
169 Krämer C, Jaspers N, Nierhoff D, Kuhr K, Bowe A, Goeser T, Michels G. Acoustic structure quantification ultrasound software proves imprecise in assessing liver fibrosis or cirrhosis in parenchymal liver diseases. Ultrasound Med Biol 2014;40:2811-8. [PMID: 25308947 DOI: 10.1016/j.ultrasmedbio.2014.07.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
170 Shen A, Zhang B, Ping J, Xie W, Donfack P, Baek S, Zhou X, Wang H, Materny A, Hu J. In vivo study on the protection of indole-3-carbinol (I3C) against the mouse acute alcoholic liver injury by micro-Raman spectroscopy: Protection of I3C against mouse liver injury by MRS. J Raman Spectrosc 2009;40:550-5. [DOI: 10.1002/jrs.2163] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
171 Nam TH, Park BJ, Sung DJ, Kim MJ, Han NY, Sim KC, Lee JH, Cho SB. Non-invasive assessment of liver fibrosis using acoustic structure quantification: comparison with transient elastography in chronic viral hepatitis. Abdom Radiol (NY) 2016;41:239-47. [PMID: 26867905 DOI: 10.1007/s00261-015-0597-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
172 Snyder N, Gajula L, Xiao SY, Grady J, Luxon B, Lau DT, Soloway R, Petersen J. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol. 2006;40:535-542. [PMID: 16825937 DOI: 10.1097/00004836-200607000-00013] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 5.4] [Reference Citation Analysis]
173 Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver Fibrosis: Noninvasive Diagnosis with Double Contrast Material–enhanced MR Imaging. Radiology 2006;239:425-37. [DOI: 10.1148/radiol.2392050505] [Cited by in Crossref: 143] [Cited by in F6Publishing: 132] [Article Influence: 9.5] [Reference Citation Analysis]
174 Afdhal NH, Curry M. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis. J Hepatol. 2007;46:543-545. [PMID: 17316879 DOI: 10.1016/j.jhep.2007.01.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
175 Sebastiani G, Vario A, Guido M, Alberti A. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepat. 2008;15:212-218. [PMID: 18179453 DOI: 10.1111/j.1365-2893.2007.00932.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
176 Giannini EG, Zaman A, Ceppa P, Mastracci L, Risso D, Testa R. A Simple Approach to Noninvasively Identifying Significant Fibrosis in Chronic Hepatitis C Patients in Clinical Practice: . Journal of Clinical Gastroenterology 2006;40:521-7. [DOI: 10.1097/00004836-200607000-00011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
177 Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology. 2008;134:1670-1681. [PMID: 18471546 DOI: 10.1053/j.gastro.2008.03.001] [Cited by in Crossref: 289] [Cited by in F6Publishing: 254] [Article Influence: 22.2] [Reference Citation Analysis]
178 Cholongitas E, Senzolo M, Standish R, Marelli L, Quaglia A, Patch D, Dhillon AP, Burroughs AK. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol. 2006;125:710-721. [PMID: 16707372 DOI: 10.1309/w3xcnt4hkfbn2g0b] [Cited by in Crossref: 151] [Article Influence: 10.1] [Reference Citation Analysis]
179 Chow AM, Gao DS, Fan SJ, Qiao Z, Lee FY, Yang J, Man K, Wu EX. Liver fibrosis: An intravoxel incoherent motion (IVIM) study. J Magn Reson Imaging 2012;36:159-67. [DOI: 10.1002/jmri.23607] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 8.7] [Reference Citation Analysis]
180 Cholongitas E, Burroughs AK, Dhillon AP. Liver Biopsy. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 762-70. [DOI: 10.1002/9781444314403.ch46] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
181 Capone F, Guerriero E, Sorice A, Maio P, Colonna G, Castello G, Costantini S. Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients. Clin Biochem 2012;45:525-9. [PMID: 22366372 DOI: 10.1016/j.clinbiochem.2012.02.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
182 Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: clinical applications. J Comput Assist Tomogr. 2013;37:887-896. [PMID: 24270110 DOI: 10.1097/rct.0000000000000032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 7.1] [Reference Citation Analysis]
183 Do RK, Rusinek H, Taouli B. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions. Magn Reson Imaging Clin N Am. 2009;17:339-349. [PMID: 19406362 DOI: 10.1016/j.mric.2009.01.009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
184 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1016/s0140-6736(08)60383-9] [Cited by in Crossref: 1212] [Cited by in F6Publishing: 491] [Article Influence: 93.2] [Reference Citation Analysis]
185 Faria SC, Ganesan K, Mwangi I, Shiehmorteza M, Viamonte B, Mazhar S, Peterson M, Kono Y, Santillan C, Casola G. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009;29:1615-1635. [PMID: 19959511 DOI: 10.1148/rg.296095512] [Cited by in Crossref: 168] [Cited by in F6Publishing: 131] [Article Influence: 15.3] [Reference Citation Analysis]
186 Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int 2013;7:356-68. [PMID: 26201770 DOI: 10.1007/s12072-013-9439-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
187 Leporq B, Saint-Jalmes H, Rabrait C, Pilleul F, Guillaud O, Dumortier J, Scoazec JY, Beuf O. Optimization of intra-voxel incoherent motion imaging at 3.0 Tesla for fast liver examination. J Magn Reson Imaging. 2015;41:1209-1217. [PMID: 25044653 DOI: 10.1002/jmri.24693] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
188 Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2016;8:166-178. [PMID: 27698966 DOI: 10.15171/mejdd.2016.29] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
189 Valva P, Casciato P, Diaz Carrasco JM, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection. PLoS One. 2011;6:e23218. [PMID: 21858035 DOI: 10.1371/journal.pone.0023218] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
190 Bae RC, Cho HJ, Oh JT, Lee EK, Heo J, Shin KY, Park SY, Jeong MK, Jeon SW, Cho CM. [Clinical factors influencing liver stiffness as measured by transient elastography (Fibroscan) in patients with chronic liver disease]. Korean J Hepatol. 2010;16:123-130. [PMID: 20606496 DOI: 10.3350/kjhep.2010.16.2.123] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
191 Shin WG, Park SH, Jun SY, Jung JO, Moon JH, Kim JP, Kim KO, Park CH, Hahn TH, Yoo KS, Kim JH, Park CK. Simple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases. Gut Liver 2007;1:145-50. [PMID: 20485631 DOI: 10.5009/gnl.2007.1.2.145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
192 Halfon P, Bourlière M, Pénaranda G, Cacoub P. [Serum markers of non-invasive fibrosis in chronic hepatitis C virus infection]. Rev Med Interne 2006;27:751-61. [PMID: 16815598 DOI: 10.1016/j.revmed.2006.03.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
193 El-hariri M, Abd El Megid AG, Taha Ali TF, Hassany M. Diagnostic value of Transient Elastography (Fibroscan) in the evaluation of liver fibrosis in chronic viral hepatitis C: Comparison to liver biopsy. The Egyptian Journal of Radiology and Nuclear Medicine 2017;48:329-37. [DOI: 10.1016/j.ejrnm.2017.03.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
194 Suk KT, Kim DY, Sohn KM, Kim DJ. Biomarkers of liver fibrosis. Adv Clin Chem 2013;62:33-122. [PMID: 24772665 DOI: 10.1016/b978-0-12-800096-0.00002-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
195 Ergelen R, Akyuz U, Aydin Y, Eren F, Yilmaz Y. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015;27:667-71. [DOI: 10.1097/meg.0000000000000342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
196 Watanabe H, Kanematsu M, Goshima S, Kondo H, Onozuka M, Moriyama N, Bae KT. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. Radiology. 2011;259:142-150. [PMID: 21248234 DOI: 10.1148/radiol.10100621] [Cited by in Crossref: 146] [Cited by in F6Publishing: 127] [Article Influence: 14.6] [Reference Citation Analysis]
197 Su LN, Guo SL, Li BX, Yang P. Diagnostic value of magnetic resonance elastography for detecting and staging of hepatic fibrosis: a meta-analysis. Clin Radiol. 2014;69:e545-e552. [PMID: 25300557 DOI: 10.1016/j.crad.2014.09.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
198 Valva P, Rios D, Casciato P, Gadano A, Galdame O, Mullen E, Bertot G, de Matteo E, Preciado MV. Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina. European Journal of Gastroenterology & Hepatology 2018;30:637-44. [DOI: 10.1097/meg.0000000000001079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
199 Patel K, Muir AJ, McHutchison JG. Diagnosis and treatment of chronic hepatitis C infection. BMJ 2006;332:1013-7. [PMID: 16644828 DOI: 10.1136/bmj.332.7548.1013] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
200 Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014;20:11033-53. [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 85] [Article Influence: 18.7] [Reference Citation Analysis]
201 Malik R, Afdhal N. Stiffness and Impedance: The New Liver Biomarkers. Clinical Gastroenterology and Hepatology 2007;5:1144-6. [DOI: 10.1016/j.cgh.2007.07.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
202 Sebastiani G, Tempesta D, Alberti A. Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus. J Viral Hepat. 2012;19:e170-e176. [PMID: 22239515 DOI: 10.1111/j.1365-2893.2011.01508.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
203 Sira MM, Behairy BE, Abd-Elaziz AM, Abd Elnaby SA, Eltahan EE. Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia. Hepat Res Treat. 2014;2014:307942. [PMID: 25295185 DOI: 10.1155/2014/307942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
204 Lee KG, Seo YS, An H, Um SH, Jung ES, Keum B, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2010;25:94-100. [DOI: 10.1111/j.1440-1746.2009.05953.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
205 Plebani M, Basso D. Non-invasive assessment of chronic liver and gastric diseases. Clin Chim Acta. 2007;381:39-49. [PMID: 17374528 DOI: 10.1016/j.cca.2007.02.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
206 Panebianco C, Oben JA, Vinciguerra M, Pazienza V. Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings. Clin Exp Med. 2017;17:269-280. [PMID: 27655446 DOI: 10.1007/s10238-016-0438-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
207 Grenier N, Quaia E, Prasad PV, Juillard L. Radiology Imaging of Renal Structure and Function by Computed Tomography, Magnetic Resonance Imaging, and Ultrasound. Seminars in Nuclear Medicine 2011;41:45-60. [DOI: 10.1053/j.semnuclmed.2010.09.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
208 Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J MagnReson Imaging. 2010;31:589-600. [PMID: 20187201 DOI: 10.1002/jmri.22081] [Cited by in Crossref: 286] [Cited by in F6Publishing: 250] [Article Influence: 26.0] [Reference Citation Analysis]
209 Lubner MG, Malecki K, Kloke J, Ganeshan B, Pickhardt PJ. Texture analysis of the liver at MDCT for assessing hepatic fibrosis. Abdom Radiol (NY). 2017;42:2069-2078. [PMID: 28314916 DOI: 10.1007/s00261-017-1096-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
210 Kim MY, Baik SK, Jang YO, Suk KT, Kim JW, Kim HS, Cho MY, Choi SJ, Um SH, Han K. Serum hyaluronic acid level: Correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model. Korean J Hepatol 2008;14:159. [DOI: 10.3350/kjhep.2008.14.2.159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
211 Kim E, Kang Y, Hahn S, Lee MJ, Park YN, Koh H. The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice. Korean J Pediatr 2013;56:19-25. [PMID: 23390441 DOI: 10.3345/kjp.2013.56.1.19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
212 Levine CD, Ghalib RH. Assessment of the Patient Who Failed Treatment for Chronic Hepatitis C: . Gastroenterology Nursing 2005;28:S24-30. [DOI: 10.1097/00001610-200505001-00005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
213 Bang CS, Kang HY, Choi GH, Kim SB, Lee W, Song IH. The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis. Korean J Gastroenterol 2017;69:298-307. [PMID: 28539035 DOI: 10.4166/kjg.2017.69.5.298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Testa R, Testa E, Giannini E, Borro P, Milazzo S, Isola L, Ceppa P, Lantieri PB, Risso D. Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index. J Intern Med. 2006;260:142-150. [PMID: 16882278 DOI: 10.1111/j.1365-2796.2006.01673.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
215 Oztas E, Kuzu UB, Zengin NI, Kalkan IH, Onder FO, Yildiz H, Celik HT, Akdogan M, Kilic MY, Koksal AS. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection? Medicine (Baltimore). 2015;94:e1889. [PMID: 26632683 DOI: 10.1097/md.0000000000001889] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
216 Huang C, Liu L, Wang H, Fang M, Feng H, Li Y, Wang M, Tong L, Xiao X, Wang Z, Xu X, He Y, Gao C. Serum N-glycan fingerprint nomogram predicts liver fibrosis: a multicenter study. Clin Chem Lab Med 2021;59:1087-97. [PMID: 33554541 DOI: 10.1515/cclm-2020-1588] [Reference Citation Analysis]
217 Segovia-Silvestre T, Reichenbach V, Fernández-Varo G, Vassiliadis E, Barascuk N, Morales-Ruiz M, Karsdal MA, Jiménez W. Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis. Fibrogenesis Tissue Repair 2011;4:19. [PMID: 21813019 DOI: 10.1186/1755-1536-4-19] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
218 Kaur I, Dogra S, De D, Kanwar AJ. Systemic Methotrexate Treatment in Childhood Psoriasis: Further Experience in 24 Children from India. Pediatr Dermatol 2008;25:184-8. [DOI: 10.1111/j.1525-1470.2008.00629.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
219 Pickhardt PJ, Graffy PM, Said A, Jones D, Welsh B, Zea R, Lubner MG. Multiparametric CT for Noninvasive Staging of Hepatitis C Virus-Related Liver Fibrosis: Correlation With the Histopathologic Fibrosis Score. AJR Am J Roentgenol 2019;212:547-53. [PMID: 30645162 DOI: 10.2214/AJR.18.20284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
220 Kumar R, Teo EK, How CH, Wong TY, Ang TL. A practical clinical approach to liver fibrosis. Singapore Med J 2018;59:628-33. [PMID: 30631885 DOI: 10.11622/smedj.2018145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
221 Lang S, Kütting F, Staub A, Schramowski J, Schramm C, Kasper P, Goeser T, Steffen HM, Demir M. Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol 2017;29:1235-40. [PMID: 28885276 DOI: 10.1097/MEG.0000000000000977] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
222 Cheung PY, Zhang Q, Zhang YO, Bai GR, Lin MC, Chan B, Fong CC, Shi L, Shi YF, Chun J. Effect of WeiJia on carbon tetrachloride induced chronic liver injury. World J Gastroenterol. 2006;12:1912-1917. [PMID: 16609998 DOI: 10.3748/wjg.v12.i12.1912] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
223 Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Saxena R, Aisen AM. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol. 2009;193:1556-1560. [PMID: 19933647 DOI: 10.2214/ajr.09.2436] [Cited by in Crossref: 147] [Cited by in F6Publishing: 44] [Article Influence: 13.4] [Reference Citation Analysis]
224 Lim AK, Patel N, Eckersley RJ, Cobbold JF, Crossey MM, Cosgrove DO, Goldin RD, Thomas HC, Taylor-Robinson SD. Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C. J Viral Hepat 2010;17:778-83. [PMID: 20002308 DOI: 10.1111/j.1365-2893.2009.01234.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
225 Rosenkrantz AB, Storey P, Gilet AG, Niver BE, Babb JS, Hajdu CH, Lee VS. Magnetization Transfer Contrast–prepared MR Imaging of the Liver: Inability to Distinguish Healthy from Cirrhotic Liver. Radiology 2012;262:136-43. [DOI: 10.1148/radiol.11111043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
226 Reshetnyak VI. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol. 2015;21:7683-7708. [PMID: 26167070 DOI: 10.3748/wjg.v21.i25.7683] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
227 Liu HB, Zhou JP, Zhang Y, Lv XH, Wang W. Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis B. Clin Chim Acta. 2011;412:33-37. [PMID: 20828546 DOI: 10.1016/j.cca.2010.08.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
228 Guglielmo FF, Venkatesh SK, Mitchell DG. Liver MR Elastography Technique and Image Interpretation: Pearls and Pitfalls. RadioGraphics 2019;39:1983-2002. [DOI: 10.1148/rg.2019190034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
229 Malik R, Lai M, Sadiq A, Farnan R, Mehta S, Nasser I, Challies T, Schuppan D, Afdhal N. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. J Gastroenterol Hepatol. 2010;25:1562-1568. [PMID: 20796156 DOI: 10.1111/j.1440-1746.2010.06371.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
230 Yu H, Touret A, Li B, O'brien M, Qureshi MM, Soto JA, Jara H, Anderson SW. Application of texture analysis on parametric T1 and T2 maps for detection of hepatic fibrosis: Texture Analysis on Parametric T1 and T2. J Magn Reson Imaging 2017;45:250-9. [DOI: 10.1002/jmri.25328] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
231 Cowan ML, Rahman TM, Krishna S. Proteomic approaches in the search for biomarkers of liver fibrosis. Trends Mol Med. 2010;16:171-183. [PMID: 20304704 DOI: 10.1016/j.molmed.2010.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
232 Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, Su GL, Ghosh M, Wright EC. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology. 2008;47:789-798. [PMID: 18175357 DOI: 10.1002/hep.22099] [Cited by in Crossref: 127] [Cited by in F6Publishing: 109] [Article Influence: 9.8] [Reference Citation Analysis]
233 Crockett SD, Kaltenbach T, Keeffe EB. Do We Still Need a Liver Biopsy? Are the Serum Fibrosis Tests Ready for Prime Time? Clinics in Liver Disease 2006;10:513-34. [DOI: 10.1016/j.cld.2006.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
234 Song P, Mellema DC, Sheedy SP, Meixner DD, Karshen RM, Urban MW, Manduca A, Sanchez W, Callstrom MR, Greenleaf JF, Chen S. Performance of 2-Dimensional Ultrasound Shear Wave Elastography in Liver Fibrosis Detection Using Magnetic Resonance Elastography as the Reference Standard: A Pilot Study. J Ultrasound Med 2016;35:401-12. [PMID: 26782164 DOI: 10.7863/ultra.15.03036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
235 Miele L, Forgione A, Gasbarrini G, Grieco A. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Transl Res. 2007;149:114-125. [PMID: 17320797 DOI: 10.1016/j.trsl.2006.11.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
236 Enomoto M, Mori M, Ogawa T, Fujii H, Kobayashi S, Iwai S, Morikawa H, Tamori A, Sakaguchi H, Sawada A. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy. Hepatol Res. 2010;40:853-861. [PMID: 20887589 DOI: 10.1111/j.1872-034x.2010.00687.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
237 Saito S, Hata K, Iwaisako K, Yanagida A, Takeiri M, Tanaka H, Kageyama S, Hirao H, Ikeda K, Asagiri M, Uemoto S. Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis. Hepatol Res 2014;44:460-73. [PMID: 23607402 DOI: 10.1111/hepr.12140] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
238 Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol. 2007;22:1904-1908. [PMID: 17914968 DOI: 10.1111/j.1440-1746.2006.04628.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
239 Gheonea DI, Săftoiu A, Ciurea T, Gorunescu F, Iordache S, Popescu GL, Belciug S, Gorunescu M, Săndulescu L. Real-time sono-elastography in the diagnosis of diffuse liver diseases. World J Gastroenterol 2010;16:1720-6. [PMID: 20380003 DOI: 10.3748/wjg.v16.i14.1720] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
240 Goshima S, Kanematsu M, Watanabe H, Kondo H, Kawada H, Moriyama N, Bae KT. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio. J Magn Reson Imaging. 2012;36:1148-1153. [PMID: 22848019 DOI: 10.1002/jmri.23758] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
241 Voumvouraki A, Koulentaki M, Notas G, Sfakianaki O, Kouroumalis E. Serum surrogate markers of liver fibrosis in primary biliary cirrhosis. Eur J Intern Med. 2011;22:77-83. [PMID: 21238899 DOI: 10.1016/j.ejim.2010.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
242 Ho AS, Cheng CC, Lee SC, Liu ML, Lee JY, Wang WM, Wang CC. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI. J Biomed Sci 2010;17:58. [PMID: 20630109 DOI: 10.1186/1423-0127-17-58] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
243 Fouad SA, Esmat S, Omran D, Rashid L, Kobaisi MH. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection. World J Gastroenterol 2012;18:2988-94. [PMID: 22736923 DOI: 10.3748/wjg.v18.i23.2988] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
244 Chow AM, Gao DS, Fan SJ, Qiao Z, Lee FY, Yang J, Man K, Wu EX. Measurement of liver T1 and T2 relaxation times in an experimental mouse model of liver fibrosis. J Magn Reson Imaging 2012;36:152-8. [DOI: 10.1002/jmri.23606] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
245 Castéra L, Bail BL, Roudot-thoraval F, Bernard P, Foucher J, Merrouche W, Couzigou P, de Lédinghen V. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. Journal of Hepatology 2009;50:59-68. [DOI: 10.1016/j.jhep.2008.08.018] [Cited by in Crossref: 259] [Cited by in F6Publishing: 212] [Article Influence: 21.6] [Reference Citation Analysis]
246 Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, Stuver S, Horsburgh CR Jr. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr. 2005;40:538-544. [PMID: 16284529 DOI: 10.1097/01.qai.0000184856.31695.bf] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 5.2] [Reference Citation Analysis]
247 Choi JY, Kim H, Sun M, Sirlin CB. Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations. Yonsei Med J 2014;55:651-9. [PMID: 24719131 DOI: 10.3349/ymj.2014.55.3.651] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
248 Iluz-Freundlich D, Grubert Van Iderstine M, Uhanova J, Zhang M, Knowles C, Minuk GY. Low serum alkaline phosphatase levels in patients with chronic liver diseases: Possible contributions to disease pathogenesis. Clin Res Hepatol Gastroenterol 2021;45:101694. [PMID: 33848667 DOI: 10.1016/j.clinre.2021.101694] [Reference Citation Analysis]
249 Park HS, Kim YJ, Yu MH, Choe WH, Jung SI, Jeon HJ. Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging. World J Gastroenterol. 2014;20:17558-17567. [PMID: 25516671 DOI: 10.3748/wjg.v20.i46.17558] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
250 Resino S, Asensio C, Bellón JM, Carmona R, Miralles P, López JC, Cosín J, Álvarez E, Berenguer J. Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: a validation study. J Infect. 2011;63:402-405. [PMID: 21839774 DOI: 10.1016/j.jinf.2011.07.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
251 Chen YP, Dai L, Wang JL, Zhu YF, Feng XR, Hou JL. Model consisting of ultrasonographic and simple blood indexes accurately identify compensated hepatitis B cirrhosis. J Gastroenterol Hepatol. 2008;23:1228-1234. [PMID: 18637057 DOI: 10.1111/j.1440-1746.2008.05421.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
252 Shen L, Li JQ, Zeng MD, Lu LG, Fan ST, Bao H. Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol. 2006;12:1292-1295. [PMID: 16534888 DOI: 10.3748/wjg.v12.i8.1292] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
253 Leung JC, Loong TC, Pang J, Wei JL, Wong VW. Invasive and non-invasive assessment of portal hypertension. Hepatol Int 2018;12:44-55. [PMID: 28361299 DOI: 10.1007/s12072-017-9795-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
254 Allan R, Thoirs K, Phillips M. Accuracy of ultrasound to identify chronic liver disease. World J Gastroenterol. 2010;16:3510-3520. [PMID: 20653059 DOI: 10.3748/wjg.v16.i28.3510] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
255 Gao X, Shi D, Chen Y, Cui J, Wang Y, Jiang C, Wu J. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. Arch Pharm Res 2012;35:1479-93. [DOI: 10.1007/s12272-012-0819-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
256 Başar O, Yimaz B, Ekiz F, Giniş Z, Altinbaş A, Aktaş B, Tuna Y, Çoban S, Delibaş N, Yüksel O. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results. Clin Res Hepatol Gastroenterol 2013;37:152-8. [PMID: 23391746 DOI: 10.1016/j.clinre.2012.07.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
257 Gressner OA, Beer N, Jodlowski A, Gressner AM. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis. Clinica Chimica Acta 2009;409:90-5. [DOI: 10.1016/j.cca.2009.09.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
258 Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR;  VA HCV-001 Study Group. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol. 2008;42:827-834. [PMID: 18285716 DOI: 10.1097/mcg.0b013e318046ea9a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
259 Subasi CF, Aykut UE, Yilmaz Y. Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27:137-141. [PMID: 25486027 DOI: 10.1097/meg.0000000000000255] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
260 Lee GM, Kim YR, Ryu JH, Kim TH, Cho EY, Lee YH, Yoon KH. Quantitative Measurement of Hepatic Fibrosis with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Chronic Hepatitis B Infection: A Comparative Study on Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index. Korean J Radiol 2017;18:444-51. [PMID: 28458596 DOI: 10.3348/kjr.2017.18.3.444] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
261 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/jci24282] [Cited by in Crossref: 3033] [Cited by in F6Publishing: 1455] [Article Influence: 189.6] [Reference Citation Analysis]
262 Antaki F, French MM, Moonka DK, Gordon SC. Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infection. Dig Dis Sci 2008;53:1957-60. [PMID: 17999186 DOI: 10.1007/s10620-007-0071-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
263 Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH. Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease. Korean J Hepatol. 2009;15:454-463. [PMID: 20037264 DOI: 10.3350/kjhep.2009.15.4.454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
264 Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol. 2014;20:4300-4315. [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 53] [Article Influence: 10.7] [Reference Citation Analysis]
265 Chin JL, Pavlides M, Moolla A, Ryan JD. Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy? Front Pharmacol. 2016;7:159. [PMID: 27378924 DOI: 10.3389/fphar.2016.00159] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
266 Hashem AM, Rasmy MEM, Wahba KM, Shaker OG. Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis C infection. Computer Methods and Programs in Biomedicine 2012;105:194-209. [DOI: 10.1016/j.cmpb.2011.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
267 Zhou L, Chen TW, Zhang XM, Yang Z, Tang HJ, Deng D, Zeng NL, Wang LY, Chen XL, Li H. Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model. J Magn Reson Imaging. 2014;39:872-878. [PMID: 24123400 DOI: 10.1002/jmri.24248] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
268 Hernández-Bartolomé A, López-Rodríguez R, Rodríguez-Muñoz Y, Martín-Vílchez S, Borque MJ, García-Buey L, González-Moreno L, Real Y, Moreno-Otero R, Sanz-Cameno P. Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link. PLoS One 2013;8:e66143. [PMID: 23823085 DOI: 10.1371/journal.pone.0066143] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
269 Alghamdi AS, Alghamdi M, Sanai FM, Alghamdi H, Aba-Alkhail F, Alswat K, Babatin M, Alqutub A, Altraif I, Alfaleh F. SASLT guidelines: Update in treatment of Hepatitis C virus infection. Saudi J Gastroenterol 2016;22 Suppl:S25-57. [PMID: 27538727 DOI: 10.4103/1319-3767.188067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
270 Hou JL, Zhao W, Lee C, Hann HW, Peng CY, Tanwandee T, Morozov V, Klinker H, Sollano JD, Streinu-Cercel A, Cheinquer H, Xie Q, Wang YM, Wei L, Jia JD, Gong G, Han KH, Cao W, Cheng M, Tang X, Tan D, Ren H, Duan Z, Tang H, Gao Z, Chen S, Lin S, Sheng J, Chen C, Shang J, Han T, Ji Y, Niu J, Sun J, Chen Y, Cooney EL, Lim SG. Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries. Clin Gastroenterol Hepatol 2020;18:457-467.e21. [PMID: 31306800 DOI: 10.1016/j.cgh.2019.07.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
271 Resino S, Bellón JM, Asensio C, Micheloud D, Miralles P, Vargas A, Catalán P, López JC, Alvarez E, Cosin J. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? BMC Infect Dis. 2010;10:244. [PMID: 20723207 DOI: 10.1186/1471-2334-10-244] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
272 de Souza-Cruz S, Victória MB, Tarragô AM, da Costa AG, Pimentel JP, Pires EF, Araújo Lde P, Coelho-dos-Reis JG, Gomes Mde S, Amaral LR, Teixeira-Carvalho A, Martins-Filho OA, Victória Fda S, Malheiro A. Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10. BMC Microbiol 2016;16:3. [PMID: 26742960 DOI: 10.1186/s12866-015-0610-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
273 Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, Sung JJ. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin Chem. 2005;51:328-335. [PMID: 15590748 DOI: 10.1373/clinchem.2004.041764] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
274 Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, Chen CW, Wang JY, Cai X, Gao CF, Zhou XQ. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005;42:1437-1445. [PMID: 16317674 DOI: 10.1002/hep.20960] [Cited by in Crossref: 111] [Cited by in F6Publishing: 109] [Article Influence: 6.9] [Reference Citation Analysis]
275 Afdhal N. Can serum markers be used to reliably detect liver fibrosis. Nat Clin Pract Gastroenterol Hepatol. 2005;2:132-133. [PMID: 16265151 DOI: 10.1038/ncpgasthep0120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
276 Yang J, Yang L, Li B, Zhou W, Zhong S, Zhuang Z, Yang B, Chen M, Feng Q. iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine. Biomed Res Int 2016;2016:3290260. [PMID: 28025641 DOI: 10.1155/2016/3290260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
277 Kawamoto M, Mizuguchi T, Katsuramaki T, Nagayama M, Oshima H, Kawasaki H, Nobuoka T, Kimura Y, Hirata K. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol 2006;12:4325-30. [PMID: 16865773 DOI: 10.3748/wjg.v12.i27.4325] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
278 Bonekamp S, Torbenson MS, Kamel IR. Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol. 2011;45:885-892. [PMID: 21716125 DOI: 10.1097/mcg.0b013e318223bd2c] [Cited by in Crossref: 69] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
279 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 87-109. [DOI: 10.1016/b978-1-4160-3258-8.50011-5] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
280 Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology 2006;43:209-20. [DOI: 10.1002/hep.21051] [Cited by in Crossref: 339] [Cited by in F6Publishing: 295] [Article Influence: 22.6] [Reference Citation Analysis]
281 Motosugi U, Ichikawa T, Sano K, Sou H, Muhi A, Koshiishi T, Ehman RL, Araki T. Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol. 2010;28:623-627. [PMID: 20972864 DOI: 10.1007/s11604-010-0478-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
282 Zhao F, Wang YX, Yuan J, Deng M, Wong HL, Chu ES, Go MY, Teng GJ, Ahuja AT, Yu J. MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication. Eur Radiol 2012;22:1709-16. [PMID: 22752522 DOI: 10.1007/s00330-012-2419-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
283 Zhang D, Wang NY, Yang CB, Fang GX, Liu W, Wen J, Luo C. The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis. Dig Dis Sci. 2010;55:767-774. [PMID: 19294506 DOI: 10.1007/s10620-009-0781-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
284 Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S, Gallois Y, Le Tallec V, Oberti F, Fouchard-Hubert I, Dib N. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int. 2009;29:1507-1515. [PMID: 19725892 DOI: 10.1111/j.1478-3231.2009.02101.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 7.3] [Reference Citation Analysis]
285 Vassiliadis E, Larsen DV, Clausen RE, Veidal SS, Barascuk N, Larsen L, Simonsen H, Silvestre TS, Hansen C, Overgaard T, Leeming DJ, Karsdal MA. Measurement of CO3-610, a potential liver biomarker derived from matrix metalloproteinase-9 degradation of collagen type iii, in a rat model of reversible carbon-tetrachloride-induced fibrosis. Biomark Insights 2011;6:49-58. [PMID: 21499440 DOI: 10.4137/BMI.S6347] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
286 Gailhouste L, Le Grand Y, Odin C, Guyader D, Turlin B, Ezan F, Désille Y, Guilbert T, Bessard A, Frémin C, Theret N, Baffet G. Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis. J Hepatol 2010;52:398-406. [PMID: 20149472 DOI: 10.1016/j.jhep.2009.12.009] [Cited by in Crossref: 114] [Cited by in F6Publishing: 89] [Article Influence: 10.4] [Reference Citation Analysis]
287 Sanai FM, Keeffe EB. Liver biopsy for histological assessment: The case against. Saudi J Gastroenterol. 2010;16:124-132. [PMID: 20339187 DOI: 10.4103/1319-3767.61244] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
288 Sayed N, Khurana A, Saifi MA, Singh M, Godugu C. Withaferin A reverses bile duct ligation‐induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signaling. BioFactors 2019;45:959-74. [DOI: 10.1002/biof.1546] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
289 Qiu C, Sha T, Yin T, Zhang W, Chen X, Miao X, Zheng R, Shuai X, Ren J. VEGFR2-targeted ultrasound molecular imaging of angiogenesis to evaluate liver allograft fibrosis. Biomater Sci 2021;9:5802-11. [PMID: 34008615 DOI: 10.1039/d1bm00100k] [Reference Citation Analysis]
290 Furusato Hunt OM, Lubner MG, Ziemlewicz TJ, Muñoz Del Rio A, Pickhardt PJ. The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures. J Comput Assist Tomogr 2016;40:478-84. [PMID: 26966951 DOI: 10.1097/RCT.0000000000000389] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
291 Karsdal MA, Krarup H, Sand JM, Christensen PB, Gerstoft J, Leeming DJ, Weis N, Schaffalitzky de Muckadell OB, Krag A. Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar. Aliment Pharmacol Ther. 2014;40:233-249. [PMID: 24909260 DOI: 10.1111/apt.12820] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
292 Wang Y, Hou JL. Current strategies for quantitating fibrosis in liver biopsy. Chin Med J (Engl) 2015;128:252-8. [PMID: 25591571 DOI: 10.4103/0366-6999.149223] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
293 Zhang Y, Jin N, Deng J, Guo Y, White SB, Yang GY, Omary RA, Larson AC. Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis. Magn Reson Imaging 2013;31:1017-21. [PMID: 23598061 DOI: 10.1016/j.mri.2013.03.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
294 Chrostek L, Panasiuk A. Liver fibrosis markers in alcoholic liver disease. World J Gastroenterol. 2014;20:8018-8023. [PMID: 25009372 DOI: 10.3748/wjg.v20.i25.8018] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
295 Lin CL, Liu CH, Wang CC, Liang CC, Su TH, Liu CJ, Kao JH. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B. J Clin Gastroenterol. 2015;49:705-713. [PMID: 25319739 DOI: 10.1097/mcg.0000000000000250] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
296 Yasuda K, Kotaka M, Toyohara T, Sueta SI, Katakai Y, Ageyama N, Uemoto S, Osafune K. A nonhuman primate model of liver fibrosis towards cell therapy for liver cirrhosis. Biochem Biophys Res Commun 2020;526:661-9. [PMID: 32248968 DOI: 10.1016/j.bbrc.2020.03.148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
297 Qin S, Zhou Y, Lok AS, Tsodikov A, Yan X, Gray L, Yuan M, Moritz RL, Galas D, Omenn GS. SRM targeted proteomics in search for biomarkers of HCV-induced progression of fibrosis to cirrhosis in HALT-C patients. Proteomics. 2012;12:1244-1252. [PMID: 22577025 DOI: 10.1002/pmic.201100601] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
298 Wang Q, Zhu H, Liu H, Zhang B. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology 2012;56:239-47. [DOI: 10.1002/hep.25610] [Cited by in Crossref: 175] [Cited by in F6Publishing: 151] [Article Influence: 19.4] [Reference Citation Analysis]
299 Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience. J Pediatr. 2013;163:1058-64.e2. [PMID: 23759423 DOI: 10.1016/j.jpeds.2013.04.044] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
300 Razek AA, Abdalla A, Omran E, Fathy A, Zalata K. Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. Eur J Radiol. 2011;78:129-134. [PMID: 19926420 DOI: 10.1016/j.ejrad.2009.10.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
301 Bourlière M, Pénaranda G, Adhoute X, Oules V, Castellani P. Combining non-invasive methods for assessment of liver fibrosis. Gastroentérologie Clinique et Biologique 2008;32:73-9. [DOI: 10.1016/s0399-8320(08)73996-4] [Cited by in Crossref: 9] [Article Influence: 0.7] [Reference Citation Analysis]
302 Kim KM, Choi WB, Park SH, Yu E, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007;42:382-388. [PMID: 17530363 DOI: 10.1007/s00535-007-2016-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
303 Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology. 2006;130:1679-1687. [PMID: 16697732 DOI: 10.1053/j.gastro.2006.02.032] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
304 Grier S, Patel N, Kuo YT, Cosgrove DO, Goldin RC, Thomas HC, Taylor-Robinson SD, Lim AK. Perihepatic lymph nodes as markers of disease response in patients with hepatitis C-related liver disease: a prospective clinical evaluation. Eur J Gastroenterol Hepatol 2010;22:257-63. [PMID: 19177027 DOI: 10.1097/MEG.0b013e3283232c7e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
305 Oh JS, Ali AK, Kim S, Corsi DJ, Cooper CL, Lee SH. NK cells lacking FcεRIγ are associated with reduced liver damage in chronic hepatitis C virus infection. Eur J Immunol 2016;46:1020-9. [PMID: 26712042 DOI: 10.1002/eji.201546009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
306 Dincses E, Yilmaz Y. Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease: . European Journal of Gastroenterology & Hepatology 2015;27:1149-53. [DOI: 10.1097/meg.0000000000000409] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
307 Chamarthi SK, Raterman B, Mazumder R, Michaels A, Oza VM, Hanje J, Bolster B, Jin N, White RD, Kolipaka A. Rapid acquisition technique for MR elastography of the liver. Magn Reson Imaging. 2014;32:679-683. [PMID: 24637083 DOI: 10.1016/j.mri.2014.02.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
308 Kocakoc E, Bakan AA, Poyrazoglu OK, Dagli AF, Gul Y, Cicekci M, Bahcecioglu IH. Assessment of Liver Fibrosis with Diffusion-Weighted Magnetic Resonance Imaging Using Different b-values in Chronic Viral Hepatitis. Med Princ Pract. 2015;24:522-526. [PMID: 26183515 DOI: 10.1159/000434682] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
309 Geng XX, Huang RG, Lin JM, Jiang N, Yang XX. Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis. Saudi J Gastroenterol. 2016;22:294-303. [PMID: 27488324 DOI: 10.4103/1319-3767.187603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
310 Abdel-Latif MS, Almahal EK, Ragab NM, Omar MF, Afifi MS. Cellular fibronectin expression in chronic hepatitis C virus patients. Scand J Infect Dis 2014;46:508-14. [PMID: 24832854 DOI: 10.3109/00365548.2014.907499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
311 Ikeda F, Okamoto R, Baba N, Fujioka S, Shoji B, Yabushita K, Ando M, Matsumura S, Kubota J, Yasunaka T. Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis. J Gastroenterol Hepatol. 2012;27:1320-1328. [PMID: 22414162 DOI: 10.1111/j.1440-1746.2012.07114.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
312 Gaia S, Campion D, Evangelista A, Spandre M, Cosso L, Brunello F, Ciccone G, Bugianesi E, Rizzetto M. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data. Liver Int 2015;35:2027-35. [PMID: 25495478 DOI: 10.1111/liv.12761] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
313 Polasek M, Fuchs BC, Uppal R, Schühle DT, Alford JK, Loving GS, Yamada S, Wei L, Lauwers GY, Guimaraes AR, Tanabe KK, Caravan P. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol 2012;57:549-55. [PMID: 22634342 DOI: 10.1016/j.jhep.2012.04.035] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 8.2] [Reference Citation Analysis]
314 Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, Ferrari A, Alberti A. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol. 2006;44:686-693. [PMID: 16490278 DOI: 10.1016/j.jhep.2006.01.007] [Cited by in Crossref: 193] [Cited by in F6Publishing: 164] [Article Influence: 12.9] [Reference Citation Analysis]
315 Lin C, Cheng Y, Chiang H, Lazo M, Chang C, Tsang L, Yu C, Hsu H, Chen W, Wang C, Liang J, Eng H, Chen C, Ou H. Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Distinguishing Hepatocellular Carcinoma From Cholangiocarcinoma in Pre–Liver Transplantation Evaluation. Transplantation Proceedings 2016;48:1041-4. [DOI: 10.1016/j.transproceed.2015.11.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
316 Kim BK, Han KH, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Kim DY. External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients. Dig Dis Sci 2010;55:2636-43. [PMID: 19960253 DOI: 10.1007/s10620-009-1070-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
317 Kaulitz R, Haber P, Sturm E, Schäfer J, Hofbeck M. Serial evaluation of hepatic function profile after Fontan operation. Herz 2014;39:98-104. [DOI: 10.1007/s00059-013-3811-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
318 Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007;13:525-31. [PMID: 17278217 DOI: 10.3748/wjg.v13.i4.525] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 85] [Article Influence: 7.0] [Reference Citation Analysis]
319 Rókusz A, Nagy E, Gerlei Z, Veres D, Dezső K, Paku S, Szücs A, Hajósi-kalcakosz S, Pávai Z, Görög D, Kóbori L, Fehérvári I, Nemes B, Nagy P. Quantitative morphometric and immunohistochemical analysis and their correlates in cirrhosis – A study on explant livers. Scandinavian Journal of Gastroenterology 2015;51:86-94. [DOI: 10.3109/00365521.2015.1067902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
320 Czul F, Bhamidimarri KR. Noninvasive Markers to Assess Liver Fibrosis. J Clin Gastroenterol 2016;50:445-57. [PMID: 27105176 DOI: 10.1097/MCG.0000000000000534] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
321 Kim SW, Kim YR, Choi KH, Cho EY, Song JS, Kim JE, Kim TH, Lee YH, Yoon KH. Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI. AJR Am J Roentgenol 2020;215:624-30. [PMID: 32755157 DOI: 10.2214/AJR.19.22041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
322 Ou H, Bonekamp S, Bonekamp D, Corona-villalobos CP, Torbenson MS, Geiger B, Kamel IR. MRI Arterial Enhancement Fraction in Hepatic Fibrosis and Cirrhosis. American Journal of Roentgenology 2013;201:W596-602. [DOI: 10.2214/ajr.12.10048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
323 Valva P, Casciato P, Lezama C, Galoppo M, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. PLoS One. 2013;8:e53519. [PMID: 23326448 DOI: 10.1371/journal.pone.0053519] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
324 Corradi F, Piscaglia F, Flori S, D’Errico-Grigioni A, Vasuri F, Tamé MR, Andreone P, Boni P, Gianstefani A, Bolondi L. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. Dig Liver Dis. 2009;41:217-225. [PMID: 18672413 DOI: 10.1016/j.dld.2008.06.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
325 Alempijevic T, Krstic M, Jesic R, Jovanovic I, Sokic Milutinovic A, Kovacevic N, Krstic S, Popovic D. Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis. World J Gastroenterol. 2009;15:591-594. [PMID: 19195061 DOI: 10.3748/wjg.15.591] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
326 Talwalkar JA. Functional hepatic imaging and disease recurrence after liver transplantation. Liver Transpl 2006;12:1744-6. [DOI: 10.1002/lt.20891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
327 Lewindon PJ, Balouch F, Pereira TN, Puertolas-Lopez MV, Noble C, Wixey JA, Ramm GA. Transient liver elastography in unsedated control children: Impact of age and intercurrent illness. J Paediatr Child Health 2016;52:637-42. [PMID: 27203205 DOI: 10.1111/jpc.13151] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
328 Cheung KJ, Libbrecht L, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis. Eur J Gastroenterol Hepatol. 2010;22:1066-1073. [PMID: 20186066 DOI: 10.1097/MEG.0b013e328337d602] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
329 Yoon JH, Lee JM, Klotz E, Jeon JH, Lee K, Han JK, Choi BI. Estimation of Hepatic Extracellular Volume Fraction Using Multiphasic Liver Computed Tomography for Hepatic Fibrosis Grading: . Investigative Radiology 2015;50:290-6. [DOI: 10.1097/rli.0000000000000123] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
330 Hagiwara M, Rusinek H, Lee VS, Losada M, Bannan MA, Krinsky GA, Taouli B. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology. 2008;246:926-934. [PMID: 18195377 DOI: 10.1148/radiol.2463070077] [Cited by in Crossref: 177] [Cited by in F6Publishing: 157] [Article Influence: 13.6] [Reference Citation Analysis]
331 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 64-85. [DOI: 10.1016/b978-1-4377-0881-3.00005-x] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
332 Kuhn J, Gressner OA, Götting C, Gressner AM, Kleesiek K. Increased serum xylosyltransferase activity in patients with liver fibrosis. Clinica Chimica Acta 2009;409:123-6. [DOI: 10.1016/j.cca.2009.09.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
333 Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, Byrnes V, Afdhal N. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2009;24:564-568. [PMID: 19378390 DOI: 10.1111/j.1440-1746.2008.05731.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
334 Onur MR, Poyraz AK, Bozdag PG, Onder S, Aygun C. Diffusion weighted MRI in chronic viral hepatitis: correlation between ADC values and histopathological scores. Insights Imaging. 2013;4:339-345. [PMID: 23666523 DOI: 10.1007/s13244-013-0252-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
335 Zissen MH, Wang ZJ, Yee J, Aslam R, Monto A, Yeh BM. Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity. AJR Am J Roentgenol. 2013;201:1204-1210. [PMID: 24261358 DOI: 10.2214/ajr.12.10039] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
336 Marinho CC, Bretas T, Voieta I, Queiroz LCD, Ruiz-guevara R, Teixeira AL, Antunes CM, Prata A, Lambertucci JR. Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for schistosomiasis mansoni: a field-based study in Brazil. Mem Inst Oswaldo Cruz 2010;105:471-8. [DOI: 10.1590/s0074-02762010000400020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
337 Kaswala DH, Lai M, Afdhal NH. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. Dig Dis Sci. 2016;61:1356-1364. [PMID: 27017224 DOI: 10.1007/s10620-016-4079-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 14.0] [Reference Citation Analysis]
338 Kim SU, Ahn SH, Park JY, Kang W, Kim do Y, Park YN, Chon CY, Han KH. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J Clin Gastroenterol. 2009;43:267-271. [PMID: 18987556 DOI: 10.1097/mcg.0b013e31816f212e] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
339 Valva P, De Matteo E, Galoppo MC, Gismondi MI, Preciado MV. Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis. J Med Virol 2010;82:949-57. [DOI: 10.1002/jmv.21699] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
340 Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360-369. [PMID: 17439526 DOI: 10.1111/j.1365-2893.2006.00811.x] [Cited by in Crossref: 461] [Cited by in F6Publishing: 415] [Article Influence: 32.9] [Reference Citation Analysis]
341 Kang SE, Lee JM, Klotz E, Kim KW, Kim JH, Han JK, Choi BI. Quantitative Color Mapping of the Arterial Enhancement Fraction in Patients With Diffuse Liver Disease. American Journal of Roentgenology 2011;197:876-83. [DOI: 10.2214/ajr.10.5943] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
342 Boursier J, Vergniol J, Guillet A, Hiriart J, Lannes A, Le Bail B, Michalak S, Chermak F, Bertrais S, Foucher J, Oberti F, Charbonnier M, Fouchard-hubert I, Rousselet M, Calès P, de Lédinghen V. Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease. Journal of Hepatology 2016;65:570-8. [DOI: 10.1016/j.jhep.2016.04.023] [Cited by in Crossref: 183] [Cited by in F6Publishing: 142] [Article Influence: 36.6] [Reference Citation Analysis]
343 Nishie A, Asayama Y, Ishigami K, Tajima T, Kakihara D, Nakayama T, Takayama Y, Okamoto D, Taketomi A, Shirabe K. MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA. J Magn Reson Imaging. 2012;36:664-671. [PMID: 22532503 DOI: 10.1002/jmri.23691] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
344 Dufour DR. Assessment of liver fibrosis: Can serum become the sample of choice. Clin Chem. 2005;51:1763-1764. [PMID: 16189374 DOI: 10.1373/clinchem.2005.056929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
345 Chen YW, Luo J, Dong C, Han X, Tateyama T, Furukawa A, Kanasaki S. Computer-aided diagnosis and quantification of cirrhotic livers based on morphological analysis and machine learning. Comput Math Methods Med 2013;2013:264809. [PMID: 24187579 DOI: 10.1155/2013/264809] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
346 Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL. Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications. Hepatology 2008;47:332-42. [DOI: 10.1002/hep.21972] [Cited by in Crossref: 232] [Cited by in F6Publishing: 199] [Article Influence: 16.6] [Reference Citation Analysis]
347 Ding H, Ma JJ, Wang WP, Zeng WJ, Jiang T, Huang BJ, Chen SY. Assessment of liver fibrosis: the relationship between point shear wave elastography and quantitative histological analysis. J Gastroenterol Hepatol. 2015;30:553-558. [PMID: 25250854 DOI: 10.1111/jgh.12789] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
348 Basturk O, Farris AB, Adsay NV. Immunohistology of the Pancreas, Biliary Tract, and Liver. Diagnostic Immunohistochemistry. Elsevier; 2011. pp. 541-92. [DOI: 10.1016/b978-1-4160-5766-6.00019-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
349 Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy. Rheumatology (Oxford). 2009;48:569-572. [PMID: 19273538 DOI: 10.1093/rheumatology/kep023] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
350 Zhao F, Yuan J, Deng M, Lu PX, Ahuja AT, Wang YX. Further exploration of MRI techniques for liver T1rho quantification. Quant Imaging Med Surg 2013;3:308-15. [PMID: 24404445 DOI: 10.3978/j.issn.2223-4292.2013.12.10] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
351 Chen S, Huang H. Clinical Non-invasive Model to Predict Liver Inflammation in Chronic Hepatitis B With Alanine Aminotransferase ≤ 2 Upper Limit of Normal. Front Med (Lausanne) 2021;8:661725. [PMID: 34150800 DOI: 10.3389/fmed.2021.661725] [Reference Citation Analysis]
352 Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun SY, Park CK. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis. 2008;40:267-274. [PMID: 18055281 DOI: 10.1016/j.dld.2007.10.011] [Cited by in Crossref: 100] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
353 Esmat G, Metwally M, Zalata KR, Gadalla S, Abdel-Hamid M, Abouzied A, Shaheen AA, El-Raziky M, Khatab H, El-Kafrawy S. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. J Hepatol. 2007;46:620-627. [PMID: 17316875 DOI: 10.1016/j.jhep.2006.12.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]